Cardiac Rhythm Management

Author Guidelines

Author Guidelines

Download the Complete Author Guidelines Pack
Download the Manuscript Submission Checklist
Download the Publishing Agreement Form
Download the ICMJE Form for Disclosure of Potential Conflicts of Interest
Download the Ethics Statement Form

Print ISSN: 2156-3977
Online ISSN: 2156-3993

General Information

The Journal of Innovations in Cardiac Rhythm Management has been in continuous publication since 2010, and is an international open access double blind peer-reviewed clinical journal published 12 times per year. The Editor-in-Chief of The Journal of Innovations in Cardiac Rhythm Management, is Moussa Mansour, MD, director of the Cardiac Electrophysiology Laboratory and director of the Atrial Fibrillation Program at Massachusetts General Hospital in Boston, MA, USA. The Journal of Innovations in Cardiac Rhythm Management, has complete editorial independence from its owner and publisher, MediaSphere Medical, LLC.

The Journal of Innovations in Cardiac Rhythm Management, is a widely circulated journal that covers the latest developments impacting the field of cardiac arrhythmia management, including advancements in ablation techniques, cardiac device therapy, anticoagulation and arrhythmia diagnosis, as well as other occurrences surrounding electrophysiology within the world. The print and online version of The Journal of Innovations in Cardiac Rhythm Management is freely available (open access).

Individuals interested in submitting a manuscript for consideration should do so online via The Journal of Innovations in Cardiac Rhythm Management, online manuscript submission and review system at http://www.editorialmanager.com/innovationsincrm. For more information, see the Submission of Manuscripts section, or contact the This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Indexing Services
CrossRef, Google Scholar, National Library of Medicine, OCLC WorldCat

Affiliated Societies
The Journal of Innovations in Cardiac Rhythm Management is affiliated with the Inter-American Society of Cardiology (SIAC) and the Latin American Society of Cardiac Stimulation and Electrophysiology (SOLAECE).

Aims and Scope
The Journal of Innovations in Cardiac Rhythm Management is a clinical journal that publishes peer-reviewed articles on the latest developments impacting the field of cardiac arrhythmia management, including advancements in device therapy and evolutions within electrophysiology. Suitable articles related to the management of complex cardiac arrhythmias, heart failure, and sudden cardiac arrest that document the state of current practice or that are relevant to clinical practice will be considered.

Editorial Office Contact Information

Aliza Becker, Managing Editor, MediaSphere Medical, LLC, 1101 Kings Highway North, Suite 440, Cherry Hill, NJ 08034, USA; Telephone: 856-320-6297; Fax: 856-438-6760; E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Submission of Manuscripts

Please refer to the Manuscript Checklist to ensure that your manuscript is complete and in compliance with our submission requirements. In particular, please check the points noted in the Manuscript Checklist before approving the PDF file of your manuscript in Editorial Manager. Manuscripts that do not conform may be returned for correction and resubmission.

Additional information can be found in the Complete Author Guidelines Pack.

Selecting a Manuscript Type

Please refer to the Manuscript Types Table on pages 22-24 of the Complete Author Guidelines Pack for complete details.

Manuscript Types
Original Research
Review
Complex Case Study
Fellows Innovations
Images in Cardiac EP
Interesting Electrocardiograms/Tracing of the Month
Expert Commentary (Invitation Only),
Expert Insights (Invitation Only)
Controversies in EP (Invitation Only).
Step-Wise Approaches
Innovative Technique and Technology Features
Letters to the Editor

Manuscript Structure

Please refer to the Manuscript Submission Checklist for specifics on what the manuscript should contain.

Examples of Reference Structure

Journal Article

1. Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficileinfection. JAMA. 2014;312(17):1772-1778.
2. Nicholson WJ, Tuohy KA, Tilkemeier P, et al. Twiddler’s syndrome. N Engl J Med. 2003;348(17):1726–1727.

Online-Only Journal Article

1. Murray CJL. Maximizing antiretroviral therapy in developing countries: the dual challenge of efficiency and quality [published online December 1, 2014]. JAMA. doi:10.1001/jama.2014.16376

Electronic Resource

1. Centers for Medicare & Medicaid Services. CMS proposals to implement certain disclosure provisions of the Affordable Care Act. http://www.cms.gov/apps/media/press/factsheet.asp?Counter=4221. Accessed January 30, 2012.

Book

1. McPhee SJ, Winker MA, Rabow MW, Pantilat SZ, Markowitz AJ, eds. Care at the Close of Life: Evidence and Experience. New York, NY: McGraw Hill Medical; 2011.

Figures

Any figures that are submitted (line drawings, halftones, photos, graphics, etc.) should be digital files that follow these guidelines:

  • High-resolution TIFF, EPS or PSD files are preferred. JPG or JPEG are also accepted.
  • ≥350 ppi.
  • ≥1200 ppi for line art.
  • Figure legends should be no more than 50 words, and should be typed separately from the figure images and placed in the main text document after the References section.
  • Each figure must be numbered and cited in the text as Figure 1, Figure 2, etc., (not Fig. 1 or Fig2). In-text citations should be superscript Arabic numerals, without brackets or parentheses, located outside sentence punctuation.
  • Regarding file naming of figure images, figures should be saved as clearly-named files so that they can easily be identified, eg, Fig 1.tif, Figure 1.jpg, or Fig2.tiff.
  • Include magnification, stain, and other pertinent data where applicable.

Tables

  • Tables should aim to be self-explanatory and supplemental, and not simply duplicate the text.
  • Brief titles should be numbered using Arabic numerals (Table 1, Table 2) according to the order in which they are mentioned in the text.
  • Each table should be typed on a separate page and designed for economy of space and readability. File submission formats can include .doc, .docx, or .pptx.
  • Notes designated in the tables and all abbreviations should be defined in a footnote. Abbreviations should be identified in the order of their use in the table.
  • All labelling should be clear and legible.

Drug Names and Dosing Information
Use the generic drug name in text, and include in parentheses any trade names that would be more recognizable to clinicians. If a specific trade name is referred to, include the manufacturer’s information. Any drug-dosing information included in the manuscript should be comprised of dose, frequency, route, and the length of time the drug was administered.

Manufacturer Information for Equipment, Devices, and Reagents
Authors should include the manufacturer or supplier, and location (city, state where applicable and country) in parentheses, after the name or description of the product, ie, VAX 3100 workstation (Digital Equipment, Marlboro, MA, USA).

English Language Services
Upon request, MediaSphere Medical will direct authors to an agent who can check and improve the English of their paper (before submission). Please contact the Managing Editor, Aliza Becker, at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or by phone at 856-320-6297 for further information.

Using Editorial Manager

To log into Editorial Manager, you must first have an online account. First-time users can visit www.editorialmanager.com/innovationsincrm to create an account by clicking “register now” and following the prompts given, and returning users can enter their username and password and choose “author” to log in. First-time users will be sent their new username and password via email upon registering. Password reset requests can also be requested on the login page.

After logging into your account, select “submit new manuscript.” Next, select the article type from the drop-down menu, and enter the article’s title on the next page. A list of submission steps will appear on the left-hand side of your submission form. The mandatory fields are indicated in red. The final submission step is to upload the text files and digital figures, which will all be converted into a PDF for use by reviewers and editorial staff. All uploaded files (with the exception of the Title Page) must be free of any author names, institutions or contact information to maintain the integrity of the blind peer review nature of the journal. Figures should also be free of any identifying patient information.

After you have attached all of your submission items, click on the “Build PDF for my approval” button. Please note that this does NOT mean that your submission has been sent to the editorial office. You will be directed to your “Submissions waiting for author approval” folder, and will be notified when the PDF is built and ready for your approval. Once the PDF is built, click on the “View Submission” action link to open the PDF. After you have reviewed the PDF and are satisfied, please close it and click on the “Approve Submission” action link. You submission will then be sent to the editorial office of The Journal of Innovations in Cardiac Rhythm Management.

Please contact the Managing Editor, Aliza Becker, via email at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or by phone at 856-320-6297 with any questions about the above-outlined submission process.

Ethics in Publishing

The Journal of Innovations in Cardiac Rhythm Management is committed to maintaining and following the highest standards of publication ethics, and to supporting ethical research practices. The Journal adheres to the Committee on Publication Ethics (COPE) (http://publicationethics.org/) Code of Conduct for Journal Publishers. We encourage journal editors to follow the COPE Code of Conduct for Journal Editors, and to refer reviewers to the COPE Ethical Guidelines for Peer Reviewers as appropriate. Allegations of misconduct will be investigated in accordance with the COPE Best Practice Guidelines. If notified of a potential breach of publication ethics, we encourage journal editors and staff to inform JICRM as soon as possible. JICRM staff is trained in how to proceed with investigations into allegations of ethical misconduct, and will seek legal counsel when necessary.

Authors may use the free tool EthicsGen at http://www.ethicsgen.com/ to generate the ethics statement for their manuscripts, or download The Journal of Innovations in Cardiac Rhythm Management’s Ethics Statement Form here. Ethics Statement information should be included as part of the Title Page of the manuscript, or can be included in the body of the manuscript where appropriate.

Authorship

Authorship confers credit and has important academic, social, and financial implications. Authorship also implies responsibility and accountability for the published work. Authors who meet all four authorship criteria of the International Committee on Medical Journal Ethics (ICJME) requirements for authorship should be included as authors of submitted manuscripts. Those contributors that meet fewer than the four authorship criteria should not be listed as authors. Instead, they may be included in the Acknowledgements section of the manuscript, which must be provided under the subheading “Acknowledgements” on the Title Page. All submissions are expected to comply with the ICMJE authorship definition. Changes to the authorship list after submission can be directed to the This e-mail address is being protected from spambots. You need JavaScript enabled to view it . Please note that such a request may result in a query from the publisher requesting written explanation.

All authors must disclose detailed information about all relevant financial interests, activities, relationships, and affiliations (other than those affiliations listed in the Title Page of the manuscript) including, but not limited to: employment; affiliation; funding and grants received or pending; consultancies; honoraria or payment; speakers' bureaus; stock ownership or options; expert testimony; royalties; donation of medical equipment; or patents planned, pending, or issued.

Conflicts of Interest Statement

The corresponding author is required to sign and submit the ICMJE Form for Disclosure of Potential Conflicts of Interest. Note: This form is required to be uploaded during the JICRM online manuscript submission process, but authors should also include conflicts of interest disclosures and Acknowledgements sections in the Title Page of the submitted manuscript when appropriate.

Funding/Support and the Role of the Funder/Sponsor

At the time of submission, information on any relevant funding sources must also be supplied on the Title Page of the manuscript. Any role of the funding organization or sponsor in any of the following should be specified, if applicable: design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and/or decision to submit the manuscript for publication.

Ethical Approval of Studies and Informed Consent

For all manuscripts reporting data from studies involving human participants or animals, formal review and approval, or formal review and waiver, by an appropriate institutional review board or ethics committee is required, and should be described in the Methods section. For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. For investigations of humans, state in the Methods section the manner in which informed consent was provided by the study participants (i.e., verbal or written) and whether participants received a stipend. Editors may request that the authors provide documentation of the formal review and recommendation from the institutional review board or ethics committee responsible for oversight of the study prior to manuscript acceptance or publication.

The Patient Consent Form for publication of identifying material is available here.

Please also refer to The Journal of Innovations in Cardiac Rhythm Management’s Ethics Statement Form for further information and assistance here.

Statement of Human and Animal Rights

When reporting studies that involve human participants, authors should include a statement that the studies have been approved by the appropriate institutional and/or national research ethics committee and have been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. If doubt exists whether the research was conducted in accordance with the 1964 Helsinki Declaration or comparable standards, the authors must explain the reasons for their approach, and demonstrate that the independent ethics committee or institutional review board explicitly approved the doubtful aspects of the study.

The welfare of animals used for research must be respected. When reporting experiments on animals, authors should indicate whether the international, national, and/or institutional guidelines for the care and use of animals have been followed, and that the studies have been approved by a research ethics committee at the institution or practice at which the studies were conducted (in places where such a committee exists).

When describing surgical procedures on animals, identify the pre-anesthetic and anesthetic agents used and state the amount of concentration and the route and frequency of administration for each. The use of paralytic agents, such as curare or succinylcholine, is not an acceptable substitute for anesthetics. For other invasive procedures on animals, report the analgesic or tranquilizing drugs used; if none were used, provide justification for such exclusion. When reporting studies on unanaesthetized animals or on humans, indicate whether the procedures followed were in accordance with institutional guidelines and why or why not.

Please refer to The Journal of Innovations in Cardiac Rhythm Management’s Ethics Statement Form for further information and assistance here.

Submission Declaration

Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis, or as an electronic preprint); that it is not under consideration for publication elsewhere; that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out; and that, if accepted, it will not be published elsewhere, including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.

Authors should note in the Title Page that the manuscript is original and that all authors are responsible for the contents and have read and approved the manuscript for submission to The Journal of Innovations in Cardiac Rhythm Management.

Clinical Trials

In accordance with the position of the International Committee of Medical Journal Editors, the journal will not consider results posted in the same clinical trials registry in which primary registration resides to be prior publication if the results posted are presented in the form of a brief structured (ie, less than 500 words) abstract or table. However, divulging results in other circumstances (eg, investors' meetings) is discouraged and may jeopardize consideration of the manuscript. Authors should fully disclose all posting in registries of results of the same or of closely related work.

Clinical Trials Registry

Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with the International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org) recommendations. Trials must register at or before the onset of patient enrollment. When applicable, the clinical trial registration number should be included at the end of the abstract of the article. The registry must be accessible to the public at no charge, be open to all prospective registrants, and be managed by a not-for-profit organization. For a list of registries that meet all of these requirements, please see the WHO International Clinical Trials Registry Platform (ICTRP). A clinical trial is defined as a research study that prospectively assigns human participants or groups of humans to one or more health-related interventions for the purpose of evaluating the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioral treatments, dietary interventions, or process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in study of patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) do not require registration.

Please refer to The Journal of Innovations in Cardiac Rhythm Management’s Ethics Statement Form for further information and assistance here.

Copyright, Permissions and Author Rights

Authors are responsible for obtaining permissions to use material, such as images, owned by others. Since the permission-seeking process can be time-consuming, it is wise to request permission as soon as possible. Permissions can be requested through Copyright Clearance Center. If further assistance is needed, please contact the This e-mail address is being protected from spambots. You need JavaScript enabled to view it directly. Please keep the originals for record.

The Journal of Innovations in Cardiac Rhythm Management is an open-access journal, without any submission, subscription, page, color, cover or open access charges required of authors, due to sponsorship. The review process is stringent and efficient. A properly completed and signed Publishing Agreement Form must be submitted with each manuscript upon submission. Upon publication, authors’ articles are immediately openly accessible. Deposit of the final article into a repository of the author’s choosing is also available at no charge.

Authors who prefer or who must publish articles under the terms of a Creative Commons Attribution-Non-commercial license can request further information from the This e-mail address is being protected from spambots. You need JavaScript enabled to view it about the Creative Commons CC BY-NC 4.0 license.

NIH/Wellcome-funded authors may submit their funded work to PMC/Europe PMC themselves, providing they submit only the final peer-reviewed manuscript that was accepted for publication (ie, post-print; this manuscript must not be altered further by any additional copyediting and typesetting service) and while observing the 12-month (NIH) or six-month (Wellcome Trust) embargo period after final publication.

Advertising Policy

The Journal of Innovations in Cardiac Rhythm Management is not dominated by advertisements, and advertising does not influence editorial decisions. The journal prohibits selling advertisements intended to be juxtaposed with editorial content on the same or a related product for the purpose of promoting a specific product. Advertisements are clearly identifiable as advertisements. Editors have full and final authority for approving print and online advertisements and for enforcing advertising policy.

JICRM does not carry advertisements for products proven to be seriously harmful to human health. Editors ensure that existing regulatory or industry standards for advertisements are enforced. The interests of organizations or agencies do not control classified and other non-display advertising, except where required by law. Editors consider all criticisms of advertisements for publication.

Peer Review Process

All manuscripts are reviewed by two independent experts in a relevant area. The reviewers make a scientific assessment and a recommendation to the editors. The reviewers remain unknown to authors, and vice versa. The handling editor considers the manuscript and the reviewers’ comments prior to making a final decision regarding publication. It is expected that all editors and reviewers handle all submissions in confidence. Editors have full editorial independence. The Journal of Innovations in Cardiac Rhythm Management will never knowingly exert pressure on editors to accept manuscripts for commercial or political reasons.

The Journal of Innovation in Cardiac Rhythm Management provides the option to authors to submit the name(s) of preferred reviewer(s). It is the responsibility of the lead author to ensure that only genuine reviewers and reviewer contact details are put forward. Any suspected or alleged instances of authors submitting fabricated reviewer details will be thoroughly investigated. If such allegations are proven, the article in question will be subject to degrees of action up to it being immediately rejected or, if already published, retracted. The journal would typically notify the authors’ institutional or local ethics council in such a case.

Journal requirements for independent data analysis and for public data availability are as follows:

Editors may request a statistical analysis of trial data by an independent biostatistician before accepting studies for publication. Authors should state whether the study data are available to third parties to view and/or use/reanalyze. Editors may encourage or require authors to share their data with others for review or reanalysis.

The journal encourages readers to submit comments, questions, or criticisms about published articles, and authors have a responsibility to respond appropriately and cooperate with any requests from the journal for data or for additional information should questions about the paper arise after publication.

For More Information

For more information on or for answers to questions regarding any of the above, please download and review the Complete Author Guidelines Pack.

For any questions about editorial policies or for assistance with manuscript submission, please contact:

Aliza Becker
Managing Editor
MediaSphere Medical, LLC
1101 Kings Highway North, Suite 440
Cherry Hill, NJ 08034
Telephone: 856-320-6297
Fax: 856-438-6760
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

mediasphere medical logo